Clinical Trials Logo

Clinical Trial Summary

This study hypothesizes that renal transplantation candidates are diagnosed with significant Coronary Artery Disease (CAD) equal with non-invasive modalities as with invasive modalities. Therefore the investigators are investigating the ability of coronary computed tomographic angiography (cCTA), myocardial perfusion scintigraphy (MPS), acoustic CAD Patch and combination hereof to detect CAD as defined by invasive Coronary angiography (CAG).


Clinical Trial Description

Chronic kidney disease is a known risk factor for cardiovascular disease and cardiovascular disease is the leading cause of mortality in end-stage renal disease (ESRD) patients. After renal transplantation one-half of all deaths are cardiac, usually in the first 5 years in the presence of a functional graft. Because of this renal transplantation candidates are undergoing cardiac pre-transplant risk stratification.

There is no consensus regarding which modality should be use for detection of CAD in this cardiac pre-transplant risk stratification. CAG is known as gold standard but is a invasive procedure with risk of complication.

The investigators wish to investigate the ability of detecting CAD as defined by invasive Coronary angiography (CAG) by clinical examination, blood test and non-invasive test (cCTA, MPS and acoustic CAD Patch). The investigators hypothesize that a single modality or combination of these with high sensitivity and specificity could diagnose significant CAD without the need of further invasive procedures.

This study will include 150 renal transplantations candidate. ;


Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms

  • Renal Transplant Candidate for Left Kidney
  • Renal Transplant Candidate for Right Kidney

NCT number NCT01344434
Study type Observational
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date February 2011
Completion date February 2014

See also
  Status Clinical Trial Phase
Recruiting NCT05411744 - One-month Latent Tuberculosis Treatment for Renal Transplant Candidates Phase 4
Completed NCT01431430 - VITamine D Supplementation in RenAL Transplant Recipients - VITALE Phase 4
Recruiting NCT05282381 - Evaluation of Regret in Kidney Transplantation